Top news of the week: 06.05.2021.
Startups
Spotting Trends and Starting Edgy Companies: Daphne Zohar on The Long Run
Today’s guest on The Long Run is Daphne Zohar. Daphne is the founder and CEO of Boston-based Puretech Health. Puretech has been around since 2005, seeking to capitalize on some of the big ...
AstraZeneca's cancer R&D exec Ferté joins Relay to run its lead asset as another bluebird exec jumps ship
Last month we found out, via Twitter, that AstraZeneca’s Charles Ferté, M.D., Ph.D., senior director and global project leader of oncology R&D, was leaving the Big Pharma, but we didn’t ...
The Case For California: Why Stories About The Golden State’s Demise Are Overblown
Here are the hard facts about why the Golden State will continue to reign supreme in technology, entertainment, agriculture and other vital industries.
Six patients with dementia went to Mexico for an unproven gene therapy, a biotech CEO claims
The study is part of an effort by entrepreneurs and scientists, dreamers and schemers, to demonstrate aging is not inevitable.
Biden Decision To Back Waiving Patents For Covid Vaccines Sparks Industry Backlash
Pharma companies said the move would curtail innovation while doing little to boost production.
These Companies Are Working On Covid Vaccines That Could Stop The Next Pandemic
Universal vaccines could be used to prevent against all variants of Covid-19, or even coronaviruses that cause other diseases.
Esker, a new biotech startup, launches with plans to make targeted immune drugs
Led by a former MyoKardia executive, Esker Therapeutics is developing a drug that could eventually compete with one of Bristol Myers Squibb's most closely watched candidates.
Roivant valued at $7B in blank-check merger, bucking SPAC slowdown
Vivek Ramaswamy's unusual biotech holding company will go public through a deal with Montes Archimedes Acquisition Corp. that nets Roivant $611 million.